John Cipriano
Net Worth
Last updated:
What is John Cipriano net worth?
The estimated net worth of Mr. John Cipriano is at least $5,564,087 as of 22 Apr 2021. He owns shares worth $544,622 as insider, has earned $286,905 from insider trading and has received compensation worth at least $4,732,560 in CEL-SCI Corporation.
What is the salary of John Cipriano?
Mr. John Cipriano salary is $225,360 per year as Senior Vice President of Regulatory Affairs in CEL-SCI Corporation.
How old is John Cipriano?
Mr. John Cipriano is 83 years old, born in 1942.
What stocks does John Cipriano currently own?
As insider, Mr. John Cipriano owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| CEL-SCI Corporation (CVM) | Senior Vice President of Regulatory Affairs | 63,108 | $8.63 | $544,622 |
What does CEL-SCI Corporation do?
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
John Cipriano insider trading
CEL-SCI Corporation
Mr. John Cipriano has made 5 insider trades between 2004-2021, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of CVM stock worth $243,790 on 22 Apr 2021.
The largest trade he's ever made was exercising 17,109 units of CVM stock on 16 Aug 2017. As of 22 Apr 2021 he still owns at least 63,108 units of CVM stock.
CEL-SCI key executives
CEL-SCI Corporation executives and other stock owners filed with the SEC:
- Dr. Daniel H. Zimmerman Ph.D. (84) Senior Vice President of Research & Cellular Immunology
- Dr. Eyal Talor Ph.D. (69) Chief Scientific Officer
- Mr. Geert R. Kersten (66) Chief Executive Officer, Principal Accounting & Financial Officer, Treasurer and Director
- Mr. John Cipriano (83) Senior Vice President of Regulatory Affairs
- Ms. Patricia B. Prichep (74) Senior Vice President of Operations & Corporation Sec.